Shane Olwill - Net Worth and Insider Trading
Shane Olwill Net Worth
The estimated net worth of Shane Olwill is at least $581 dollars as of 2024-06-11. Shane Olwill is the Chief Development Officer of Pieris Pharmaceuticals Inc and owns about 58 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $581. Details can be seen in Shane Olwill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shane Olwill has not made any transactions after 2021-08-30 and currently still holds the listed stock(s).
Transaction Summary of Shane Olwill
Shane Olwill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shane Olwill owns 1 companies in total, including Pieris Pharmaceuticals Inc (PIRS) .
Click here to see the complete history of Shane Olwill’s form 4 insider trades.
Insider Ownership Summary of Shane Olwill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2023-02-24 | Chief Development Officer |
Shane Olwill Latest Holdings Summary
Shane Olwill currently owns a total of 1 stock. Shane Olwill owns 58 shares of Pieris Pharmaceuticals Inc (PIRS) as of August 30, 2021, with a value of $581.
Latest Holdings of Shane Olwill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2021-08-30 | 58 | 10.01 | 581 |
Holding Weightings of Shane Olwill
Shane Olwill Form 4 Trading Tracker
According to the SEC Form 4 filings, Shane Olwill has made a total of 1 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pieris Pharmaceuticals Inc is the sale of 480 shares on August 30, 2021, which brought Shane Olwill around $196,224.
Insider Trading History of Shane Olwill
- 1
Shane Olwill Trading Performance
Shane Olwill Ownership Network
Shane Olwill Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Shane Olwill is the Chief Development Officer of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Shane Olwill made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 10,000 shares made by Christopher P Kiritsy ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 125 shares were bought by its insiders, resulting in a net purchase of 125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Shane Olwill Mailing Address
Above is the net worth, insider trading, and ownership report for Shane Olwill. You might contact Shane Olwill via mailing address: C/o Pieris Pharmaceuticals, Inc., 255 State Street, 9th Floor, Boston Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
